146 related articles for article (PubMed ID: 2523869)
1. Mammary adenocarcinomas induced by medroxyprogesterone acetate: hormone dependence and EGF receptors of BALB/c in vivo sublines.
Lanari C; Kordon E; Molinolo A; Pasqualini CD; Charreau EH
Int J Cancer; 1989 May; 43(5):845-50. PubMed ID: 2523869
[TBL] [Abstract][Full Text] [Related]
2. Effect of sialoadenectomy on medroxyprogesterone-acetate-induced mammary carcinogenesis in BALB/c mice. Correlation between histology and epidermal-growth-factor receptor content.
Kordon EC; Guerra F; Molinolo AA; Elizalde P; Charreau EH; Pasqualini CD; Montecchia F; Pazos P; Dran G; Lanari C
Int J Cancer; 1994 Oct; 59(2):196-203. PubMed ID: 7927919
[TBL] [Abstract][Full Text] [Related]
3. Estrogen inhibition of MPA-induced mouse mammary tumor transplants.
Kordon E; Lanari C; Molinolo AA; Elizalde PV; Charreau EH; Dosne Pasqualini C
Int J Cancer; 1991 Dec; 49(6):900-5. PubMed ID: 1835715
[TBL] [Abstract][Full Text] [Related]
4. Mouse mammary tumors induced by medroxyprogesterone acetate: immunohistochemistry and hormonal receptors.
Molinolo AA; Lanari C; Charreau EH; Sanjuan N; Pasqualini CD
J Natl Cancer Inst; 1987 Dec; 79(6):1341-50. PubMed ID: 2826865
[TBL] [Abstract][Full Text] [Related]
5. Reversal of estrogen-resistance in murine mammary adenocarcinomas.
Montecchia MF; Molinolo A; Lanari C
Breast Cancer Res Treat; 1999 Mar; 54(2):93-9. PubMed ID: 10424399
[TBL] [Abstract][Full Text] [Related]
6. Hormone dependence of a mouse mammary tumor line induced in vivo by medroxyprogesterone acetate.
Kordon E; Lanari C; Meiss R; Elizalde P; Charreau E; Dosne Pasqualini C
Breast Cancer Res Treat; 1990 Nov; 17(1):33-43. PubMed ID: 2151368
[TBL] [Abstract][Full Text] [Related]
7. [Progestin-induced mammary adenocarcinomas in BALB/c mice. Progression from hormone-dependent to autonomous tumors].
Lanari C; Montecchia MF; Pazos P; Simian M; Vanzulli S; Lamb C; Molinolo AA
Medicina (B Aires); 1997; 57 Suppl 2():55-69. PubMed ID: 9567344
[TBL] [Abstract][Full Text] [Related]
8. Mammary carcinogenesis induced by N-methyl-N-nitrosourea (MNU) and medroxyprogesterone acetate (MPA) in BALB/c mice.
Pazos P; Lanari C; Meiss R; Charreau EH; Pasqualini CD
Breast Cancer Res Treat; 1992 Jan; 20(2):133-8. PubMed ID: 1554889
[TBL] [Abstract][Full Text] [Related]
9. Progesterone receptor involvement in independent tumor growth in MPA-induced murine mammary adenocarcinomas.
Montecchia MF; Lamb C; Molinolo AA; Luthy IA; Pazos P; Charreau E; Vanzulli S; Lanari C
J Steroid Biochem Mol Biol; 1999 Jan; 68(1-2):11-21. PubMed ID: 10215033
[TBL] [Abstract][Full Text] [Related]
10. Progesterone induction of mammary carcinomas in BALB/c female mice. Correlation between progestin dependence and morphology.
Kordon EC; Molinolo AA; Pasqualini CD; Charreau EH; Pazos P; Dran G; Lanari C
Breast Cancer Res Treat; 1993 Oct; 28(1):29-39. PubMed ID: 8123867
[TBL] [Abstract][Full Text] [Related]
11. Correlation of TGF-beta 1 expression with medroxyprogesterone acetate responsiveness in mouse mammary adenocarcinomas.
Elizalde PV; Guerra FK; Gravano M; Lanari C; Lippman ME; Charreau EH; Lupu R
Cancer Invest; 1995; 13(2):173-80. PubMed ID: 7874571
[TBL] [Abstract][Full Text] [Related]
12. Induction of mammary adenocarcinomas by medroxyprogesterone acetate in BALB/c female mice.
Lanari C; Molinolo AA; Pasqualini CD
Cancer Lett; 1986 Nov; 33(2):215-23. PubMed ID: 2947675
[TBL] [Abstract][Full Text] [Related]
13. Transforming growth factor-beta activities in 'in vivo' lines of hormone-dependent and independent mammary adenocarcinomas induced by medroxyprogesterone acetate in BALB/c mice.
Elizalde PV; Lanari C; Kordon E; Tezón J; Charreau EH
Breast Cancer Res Treat; 1990 Jul; 16(1):29-39. PubMed ID: 2145045
[TBL] [Abstract][Full Text] [Related]
14. Five novel hormone-responsive cell lines derived from murine mammary ductal carcinomas: in vivo and in vitro effects of estrogens and progestins.
Lanari C; Lüthy I; Lamb CA; Fabris V; Pagano E; Helguero LA; Sanjuan N; Merani S; Molinolo AA
Cancer Res; 2001 Jan; 61(1):293-302. PubMed ID: 11196177
[TBL] [Abstract][Full Text] [Related]
15. Involvement of EGF in medroxyprogesterone acetate (MPA)-induced mammary gland hyperplasia and its role in MPA-induced mammary tumors in BALB/c mice.
Molinolo A; Simian M; Vanzulli S; Pazos P; Lamb C; Montecchia F; Lanari C
Cancer Lett; 1998 Apr; 126(1):49-57. PubMed ID: 9563648
[TBL] [Abstract][Full Text] [Related]
16. Effect of medroxyprogesterone acetate (MPA) and serum factors on cell proliferation in primary cultures of an MPA-induced mammary adenocarcinoma.
Dran G; Luthy IA; Molinolo AA; Montecchia F; Charreau EH; Pasqualini CD; Lanari C
Breast Cancer Res Treat; 1995 Aug; 35(2):173-86. PubMed ID: 7647339
[TBL] [Abstract][Full Text] [Related]
17. Opposite effect of a cAMP analogue on tumoral growth related to hormone dependence of a murine mammary tumor.
Actis AM; Caruso SP; Levin E
Cancer Lett; 1995 Sep; 96(1):81-5. PubMed ID: 7553611
[TBL] [Abstract][Full Text] [Related]
18. [Growth hormones and oncogenes in mammary adenocarcinomas induced by medroxyprogesterone acetate in BALB/c mice].
Elizalde PV; Balaña ME; Charreau EH
Medicina (B Aires); 1997; 57 Suppl 2():70-4. PubMed ID: 9580484
[TBL] [Abstract][Full Text] [Related]
19. Involvement of insulin-like growth factors-I and -II and their receptors in medroxyprogesterone acetate-induced growth of mouse mammary adenocarcinomas.
Elizalde PV; Lanari C; Molinolo AA; Guerra FK; Balañá ME; Simian M; Iribarren AM; Charreau EH
J Steroid Biochem Mol Biol; 1998 Nov; 67(4):305-17. PubMed ID: 9883987
[TBL] [Abstract][Full Text] [Related]
20. Association of estrogen receptor-alpha and progesterone receptor A expression with hormonal mammary carcinogenesis: role of the host microenvironment.
Montero Girard G; Vanzulli SI; Cerliani JP; Bottino MC; Bolado J; Vela J; Becu-Villalobos D; Benavides F; Gutkind S; Patel V; Molinolo A; Lanari C
Breast Cancer Res; 2007; 9(2):R22. PubMed ID: 17341305
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
